• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BNT162b2 和科兴疫苗接种与 COVID-19 感染后 CVD 和死亡率风险的关联:一项基于人群的队列研究。

Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study.

机构信息

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China; Laboratory of Data Discovery for Health (D(2)4H), Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

出版信息

Cell Rep Med. 2023 Oct 17;4(10):101195. doi: 10.1016/j.xcrm.2023.101195. Epub 2023 Sep 15.

DOI:10.1016/j.xcrm.2023.101195
PMID:37716352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10591029/
Abstract

It is unknown if vaccination affects the risk of post-COVID-19 cardiovascular diseases (CVDs). Therefore, this retrospective cohort study examines the short-term and long-term risks of post-infection CVD among COVID-19 patients with different vaccination status utilizing data from electronic health databases in Hong Kong. Cox proportional hazards regression adjusted with inverse probability of treatment weighting is used to evaluate the risks of incident CVD (coronary heart disease, stroke, heart failure) and all-cause mortality in COVID-19 patients. Compared with unvaccinated patients, vaccinated patients have a lower risk of CVD and all-cause mortality, and the lowest risk is observed in those who completed three doses of vaccine. Similar patterns in the subgroups of different vaccine platforms, age, gender, Charlson comorbidity index, and disease severity are observed. These findings highlight a positive dose-response relationship between overall CVD risk reduction and the number of vaccine doses received.

摘要

目前尚不清楚疫苗接种是否会影响 COVID-19 后心血管疾病(CVD)的风险。因此,本回顾性队列研究利用香港电子健康数据库中的数据,检查了不同疫苗接种状态的 COVID-19 患者感染后 CVD 的短期和长期风险。使用逆概率治疗加权的 Cox 比例风险回归来评估 COVID-19 患者新发 CVD(冠心病、中风、心力衰竭)和全因死亡率的风险。与未接种疫苗的患者相比,接种疫苗的患者 CVD 和全因死亡率的风险较低,而接种三剂疫苗的患者风险最低。在不同疫苗平台、年龄、性别、Charlson 合并症指数和疾病严重程度的亚组中观察到类似的模式。这些发现强调了 CVD 总体风险降低与接种疫苗剂量之间的正剂量反应关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/2b758978b792/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/ebd13664513b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/abb86e405004/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/2b758978b792/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/ebd13664513b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/abb86e405004/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b3/10591029/2b758978b792/gr2.jpg

相似文献

1
Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study.BNT162b2 和科兴疫苗接种与 COVID-19 感染后 CVD 和死亡率风险的关联:一项基于人群的队列研究。
Cell Rep Med. 2023 Oct 17;4(10):101195. doi: 10.1016/j.xcrm.2023.101195. Epub 2023 Sep 15.
2
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
3
Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.香港 COVID-19 疫苗接种和 SARS-CoV-2 感染后糖尿病的发病率:一项基于人群的队列研究。
PLoS Med. 2023 Jul 24;20(7):e1004274. doi: 10.1371/journal.pmed.1004274. eCollection 2023 Jul.
4
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
5
Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.甲状腺功能减退症患者接种灭活新冠疫苗和 mRNA 新冠疫苗的安全性:一项基于人群的队列研究。
Thyroid. 2022 May;32(5):505-514. doi: 10.1089/thy.2021.0684. Epub 2022 Apr 7.
6
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 omicron infection and related hospital admission among people with substance use disorder in Hong Kong: a matched case-control study.BNT162b2 和科兴疫苗对香港有药物滥用史人群感染奥密克戎和相关住院的有效性:一项匹配病例对照研究。
Lancet Psychiatry. 2023 Jun;10(6):403-413. doi: 10.1016/S2215-0366(23)00111-6. Epub 2023 May 1.
7
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.60 岁及以上人群中接种 BNT162b2 和科兴疫苗对奥密克戎感染的有效性:病例对照研究。
J Travel Med. 2022 Dec 27;29(8). doi: 10.1093/jtm/taac119.
8
Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study.两剂 COVID-19 疫苗(BNT162b2 和科兴)在癌症成人中的安全性:全港范围队列研究。
J Hematol Oncol. 2022 May 19;15(1):66. doi: 10.1186/s13045-022-01265-9.
9
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.mRNA(BNT162b2)和灭活(科兴)新冠疫苗接种后的自身免疫状况:香港 110 万人接种疫苗的描述性队列研究。
J Autoimmun. 2022 Jun;130:102830. doi: 10.1016/j.jaut.2022.102830. Epub 2022 Apr 14.
10
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.

引用本文的文献

1
COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks.2019冠状病毒病疫苗接种与心血管事件:预防性益处和风险的系统评价与贝叶斯多变量荟萃分析
Int J Prev Med. 2025 Mar 21;16:14. doi: 10.4103/ijpvm.ijpvm_260_24. eCollection 2025.
2
Factors Associated with Post-COVID Cardiac Conditions and Potential Prognostic Factors: A Systematic Review.与新冠后心脏疾病相关的因素及潜在预后因素:一项系统综述
Life (Basel). 2025 Feb 28;15(3):388. doi: 10.3390/life15030388.
3
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review.

本文引用的文献

1
Prolonged peripheral seronegative spondyloarthritis following BioNTech coronavirus disease 2019 vaccination: A case report.接种BioNTech新冠疫苗后出现的长期外周血清阴性脊柱关节炎:一例报告。
Int J Rheum Dis. 2023 Apr;26(4):774-777. doi: 10.1111/1756-185X.14512. Epub 2022 Dec 8.
2
The Costs of Long COVID.长期新冠的代价
JAMA Health Forum. 2022 May 6;3(5):e221809. doi: 10.1001/jamahealthforum.2022.1809.
3
Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study.
影响新冠病毒疫苗接种对成人新冠后状况影响的因素:一项系统文献综述
Hum Vaccin Immunother. 2025 Dec;21(1):2474772. doi: 10.1080/21645515.2025.2474772. Epub 2025 Mar 13.
4
Local adaptive immunity in atherosclerosis with T cell activation by aortic dendritic cells accelerates pathogenesis.主动脉树突状细胞激活T细胞,引发动脉粥样硬化中的局部适应性免疫,加速疾病进展。
iScience. 2024 Oct 10;27(11):111144. doi: 10.1016/j.isci.2024.111144. eCollection 2024 Nov 15.
无合并症患者长期新冠的预测因素:来自波兰长期新冠心血管(PoLoCOV-CVD)研究的数据。
J Clin Med. 2022 Aug 25;11(17):4980. doi: 10.3390/jcm11174980.
4
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.BNT162b2和科兴新冠疫苗对糖尿病患者感染新型冠状病毒奥密克戎BA.2、住院、严重并发症、心血管疾病及死亡的疫苗效力:一项病例对照研究
J Infect. 2022 Nov;85(5):e140-e144. doi: 10.1016/j.jinf.2022.08.008. Epub 2022 Aug 17.
5
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.BNT162b2 和科兴疫苗对奥密克戎 BA.2 感染后死亡和重症并发症的有效性:一项病例对照研究。
Emerg Microbes Infect. 2022 Dec;11(1):2304-2314. doi: 10.1080/22221751.2022.2114854.
6
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks.未接种疫苗人群中新冠病毒病康复者的长期心血管结局:一项来自TriNetX美国协作网络的回顾性队列研究
EClinicalMedicine. 2022 Nov;53:101619. doi: 10.1016/j.eclinm.2022.101619. Epub 2022 Aug 11.
7
Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.接种疫苗与 COVID-19 感染后急性心肌梗死和缺血性卒中的关联。
JAMA. 2022 Sep 6;328(9):887-889. doi: 10.1001/jama.2022.12992.
8
COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods.美国退伍军人在奥密克戎和德尔塔变异株流行期间感染 COVID-19 的疾病严重程度。
Nat Commun. 2022 Jun 25;13(1):3647. doi: 10.1038/s41467-022-31402-4.
9
Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series.COVID-19 mRNA 疫苗接种后的心肌炎:病例报告和病例系列的系统评价。
Clin Cardiol. 2022 Jul;45(7):691-700. doi: 10.1002/clc.23828. Epub 2022 Jun 2.
10
Can COVID-19 vaccines improve cardiovascular outcomes?新冠病毒疫苗能否改善心血管结局?
Travel Med Infect Dis. 2022 Jul-Aug;48:102350. doi: 10.1016/j.tmaid.2022.102350. Epub 2022 Apr 29.